

Please try another search
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company's segments include Consumer & Research Services and Therapeutics. The Consumer & Research Services segment comprises its Personal Genome Service (PGS), telehealth business, and research services. Its PGS service provides customers with a suite of genetic reports, including information on customers genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. Its telehealth platform provides patients with access to medical consultation and treatment. Through its research services, it uses its database of genetic and phenotypic information to identify targets for drug development. The Therapeutics segment focuses on the use of genetic insights from its database of genetic and phenotypic information to develop therapies to improve patients lives.
Name | Age | Since | Title |
---|---|---|---|
Anne Wojcicki | - | 2006 | Co-Founder, CEO, President & Director |
Patrick S. Chung | - | 2021 | Independent Director |
Evan M. Lovell | 52 | 2021 | Director |
Peter J. Taylor | 63 | 2021 | Independent Director |
Richard H. Scheller | 69 | 2015 | Director |
Roelof Frederik Botha | 49 | 2021 | Independent Director |
Neal Mohan | 49 | 2021 | Independent Director |
Valerie C. Montgomery Rice | 60 | 2021 | Independent Director |
Sandra R. Hernandez | 65 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review